Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dutton update today

"We reiterate our Strong Speculative Buy Rating and our $0.55 per share price target."

blah blah, blah blah

:)

Share
New Message
Please login to post a reply